Artificial Intelligence | Machine Learning | Machine Perception Charm Therapeutics | Unfolding the Future of Medicine Through 3D Deep Learning Technology


Enterprise, BioTech, Drug Discovery, Molecular Diagnostics Cancer Reserch, 3D Technology London , United Kingdom

Charm Therapeutics

Artificial Intelligence | Machine Learning | Machine Perception


Charm Therapeutics | Unfolding the Future of Medicine Through 3D Deep Learning Technology

Charm Therapeutics

BioTech, Drug Discovery, Molecular Diagnostics Cancer Reserch, 3D Technology


London , United Kingdom

We are delivering transformational medicines through 3D deep learning and cutting-edge drug discovery technologies. By applying revolutionary insights in 3D protein-ligand co-folding, we seek to target previously undruggable disease targets. We are an entrepreneurial team of extraordinary scientists, engineers, and entrepreneurs, purpose-built to meld cutting-edge know-how from 3D deep learning and drug discovery.

85% of the human proteome remains undruggable – we are seeking to change that. We are developing a pipeline of truly novel small molecule inhibitors targeting cancers and other diseases with high unmet medical needs. We have created DragonFold, our end-to-end algorithm that predicts protein/ligand co-folding to discover novel transformational medicines for hard-to-drug targets.

We apply proprietary expertise to the challenge of protein/ligand co-folding to discover and develop a new wave of novel medicines for cancer and other indications. Our DragonFold technology, inspired by the breakthroughs of our co-founder and Wiley- Prize winner David Baker, is the first rapid, accurate protein/ligand co-folding algorithm. We use our state-of-the-art lab facilities to validate our AI-derived medicines in an integrative loop, striving to bring them to patients as fast as possible.

 

B2B

1 to 25

N/A

N/A

Scaling Up

2021

 
 

Research & Consulting Services
Information Technology and Services

Drug Discovery Technologies
3D Deep Learning

Increase Efficiency
Increase Productivity

 
 

Analytics
Service

Yes

Active

 
 

   Machine Learning
   Machine Perception
   Natural Language Processing
   Automated Planning and Search


Biotechnology

Biotechnology

Molecular Biology

Molecular Biology


Image

Image

Video

Video

Text

Text

Structured

Structured

 

   Software


Pytorch

Pytorch

Python

Python

C/C++

C/C++

Angular

Angular

Unix/Linux

Unix/Linux

Django

Django


3D Mapping Algorithms

3D Mapping Algorithms

Machine Learning Algorithm

Machine Learning Algorithm

Deep Learning Algorithm

Deep Learning Algorithm

 
 

5

1

$50M

Company was founded 2021 and it took almost 1 year (Jun 2022) to raise first external round

 
 

Date

Round

$ Raised

Investors

06/13/2022

Series A

$50M

F-Prime Capital, OrbiMed, General Catalyst, Khosla Ventures, Axial VC

Date : 06/13/2022

Round: Series A

$ Raised: $50M

Investors: F-Prime Capital, OrbiMed, General Catalyst, Khosla Ventures, Axial VC

 

Investors

Interested in researching Charm Therapeutics?

We have plenty of data and we can help. Our deal sourcing platform can help you perform more research about Charm Therapeutics

Request a Demo - Deal Souring Platform

 
Laksh Aithani

Laksh Aithani
Founder, CEO and President

Andrew Dore

Andrew Dore
Vice President

 
 

Potential Customers

Interested in what they do or partnership?

Learn more about how they work

Schedule a Call w/ Charm Therapeutics